Home page for MMWR
| MMWR
Skip directly to site content
Skip directly to search
EspaÃ±ol |
Other Languages
An official website of the United States government Here's how you know
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.
Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
Search
Submit
Morbidity and Mortality Weekly Report (MMWR)
Home page for MMWR
Print
Minus
Related Pages
August 25, 2023Notes from the Field: Asthma-Associated Emergency Department Visits During a Wildfire Smoke Event — New York, June 2023
Read MoreJune 30, 2023Travel-Related Diagnoses Among U.S. Nonmigrant Travelers or Migrants Presenting to U.S. GeoSentinel Sites — GeoSentinel Network, 2012–2021
Read MoreJune 23, 2023E-cigarette Unit Sales by Product and Flavor Type, and Top-Selling Brands, United States, 2020–2022
Read MoreSeptember 25, 2025Pediatric Influenza-Associated Encephalopathy and Acute Necrotizing Encephalopathy — United States, 2024–25 Influenza Season
Read MoreSeptember 18, 2025Clinical Recommendation for the Use of Injectable Lenacapavir as HIV Preexposure Prophylaxis — United States, 2025
Read MoreSeptember 11, 2025Influenza-Associated Hospitalizations During a High Severity Season — Influenza Hospitalization Surveillance Network, United States, 2024–25 Influenza Season
Read More
Latest Reports
MMWR Weekly Report
Pediatric Influenza-Associated Encephalopathy and Acute Necrotizing Encephalopathy — United States, 2024–25 Influenza Season
Influenza-Associated Pediatric Deaths — United States, 2024–25 Influenza Season
Interim Effectiveness Estimates of 2025 Southern Hemisphere Influenza Vaccines in Preventing Influenza-Associated Outpatient and Hospitalized Illness — Eight Southern Hemisphere Countries, March–September 2025
Latest Reports
COVID-19 Mortality and Progress Toward Vaccinating Older Adults — World Health Organization, Worldwide, 2020–2022
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5- and XBB/XBB.1.5-Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing Program, United States, December 2022–January 2023
Spike Gene Target Amplification in a Diagnostic Assay as a Marker for Public Health Monitoring of Emerging SARS-CoV-2 Variants — United States, November 2021–January 2023
Information for Persons Who Are Immunocompromised Regarding Prevention and Treatment of SARS-CoV-2 Infection in the Context of Currently Circulating Omicron Sublineages — United States, January 2023
QuickStats: Percentage of Persons Who Used Telemedicine Within the Previous 12 Months, by Age Group — National Health Interview Survey, United States, 2021
More Reports
Search All Reports
Browse by TopicFlu
RSV
MpoxVaccines
Tobacco
Overdose
View all Topics
Browse by PublicationWeekly ReportRecommendations and ReportsSurveillance SummariesSupplements
View all Publications
ResourcesFor Authors Continuing EducationVital SignsMMWR Clinical PearlsAbout Us
NewslettersRead MMWR Clinical Pearls Newsletter
InfographicsSee infographic summaries of reports
PodcastsListen and subscribe to the MMWR podcast
Get the latest from MMWRSubscribe
Last Reviewed:
September 25, 2025 Source: 	Centers for Disease Control and Prevention
Facebook
Twitter
LinkedIn
Syndicate
MMWRReports by TopicPublicationsplus iconWeekly Reportplus iconPast Volumes (1982-2024)Recommendations and Reportsplus iconPast Volumes (1990-2024)Surveillance Summariesplus iconPast Volumes (1983-2024)Supplementsplus iconPast Volumes (1985-2023)Archive (1952-1981)Notifiable Infectious DiseasesNotifiable Noninfectious ConditionsVital SignsInfographicsPodcastsContinuing EducationMMWR Clinical PearlsFor AuthorsAbout  plus iconStaffEditorial BoardSubscribeplus iconRSS Feed
About CDC
Contact Us
800-232-4636
Facebook
Twitter
Instagram
LinkedIn
Youtube
Pinterest
Snapchat
RSS
CONTACT CDC
Contact Us
Call 800-232-4636
Email Us
ABOUT CDC
About CDC
Jobs
Funding
POLICIES
Accessibility
External Links
Privacy
Web Policies
FOIA
OIG
No Fear Act
Nondiscrimination
Vulnerability Disclosure Policy
CDC Archive
Public Health Publications
HHS.gov
USA.gov
CONNECT WITH US
Facebook
Twitter
Instagram
LinkedIn
Youtube
Pinterest
Snapchat
Email
LANGUAGES
EspaÃ±ol
ç¹é«ä¸­æ
Tiáº¿ng Viá»t
íêµ­ì´
Tagalog
Ð ÑÑÑÐºÐ¸Ð¹
Ø§ÙØ¹Ø±Ø¨ÙØ©
KreyÃ²l Ayisyen
FranÃ§ais
Polski
PortuguÃªs
Italiano
Deutsch
æ¥æ¬èª
ÙØ§Ø±Ø³Û
English
Accessibility
External Links
Privacy
Web Policies
FOIA
OIG
No Fear Act
Nondiscrimination
Vulnerability Disclosure Policy
CDC Archive
Public Health Publications
HHS.gov
USA.gov
SAS
stats